Clinical Trial Update: Second-line Treatment of Primary Autoimmune Hemolytic Anemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for second-line treatment of primary autoimmune hemolytic anemia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia

Snippet

Sponsor: Assiut University | Conditions: Primary Autoimmune Hemolytic Anemia | Phase 3 | Status: RECRUITING